… lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) diagnosed in core needle
biopsy … indicators for developing invasive ductal or lobular carcinoma in either breast. Currently…

Context.—Both atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) have
traditionally been considered to be risk factors for the development of invasive carcinoma …

… The treatment of patients with ALH or LCIS diagnosed at percutaneous core-needle biopsy
(… biopsy originates from conflicting opinions with respect to the biologic behavior of lobular …

… Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular carcinoma
in situ (LCIS). LN often is an incidental finding on breast core needle biopsy (CNBx) and …

… or LCIS is the lesion with highest risk at core-needle biopsy. Cases in which ALH or LCIS
was … scar, atypical ductal hyperplasia) were omitted, as they would require excisional biopsy. …

… Photomicrograph of atypical lobular hyperplasia associated with columnar cell changes and
… analysis, and biopsies containing coexisting atypical ductal hyperplasia, ductal carcinoma …

… had biopsies with either 11 or 14-gauge needles under … core needle biopsies using other
devices or needle sizes. Additional limitations include the relatively small number of biopsies …

… We also show data that supports clinically following patients with lobular carcinoma in situ
and atypical lobular hyperplasia on core needle biopsy when the lesion is not associated with …

… in every case after core needle biopsy, especially in cases of lobular neoplasia. In one series
( , 3), microcalcifications depicted at mammography were the indication for biopsy in 49% …

… We suggest that patients with LCIS/ALH on core needle biopsy should be considered for
surgical excision to rule out a more significant lesion regardless of the histologic features. …